Dohlsten M - Search Results

1

Superantigen-mediated cellular cytotoxicity is dependent on antigen expression, but independent of the P-glycoprotein multidrug resistance phenotype.

Zehrer C, Beck J, Gekeler V, Ihle J, Holzer U, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Zehrer C, et al. Among authors: dohlsten m. Br J Haematol. 1996 Dec;95(3):452-6. doi: 10.1046/j.1365-2141.1996.d01-1938.x. Br J Haematol. 1996. PMID: 8943883

2

Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.

Ihle J, Holzer U, Krull F, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Ihle J, et al. Among authors: dohlsten m. Cancer Res. 1995 Feb 1;55(3):623-8. Cancer Res. 1995. PMID: 7530598

3

Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.

Holzer U, Bethge W, Krull F, Ihle J, Handgretinger R, Reisfeld RA, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Holzer U, et al. Among authors: dohlsten m. Cancer Immunol Immunother. 1995 Aug;41(2):129-36. doi: 10.1007/BF01527409. Cancer Immunol Immunother. 1995. PMID: 7656271 Free PMC article.

4

T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.

Holzer U, Orlikowsky T, Zehrer C, Bethge W, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Holzer U, et al. Among authors: dohlsten m. Immunology. 1997 Jan;90(1):74-80. doi: 10.1046/j.1365-2567.1997.00141.x. Immunology. 1997. PMID: 9038715 Free PMC article.

5

Superantigen-induced lysis of melanoma cells.

Krull F, Holzer U, Ihle J, Bethge W, Fierlbeck G, Kalland T, Dohlsten M, Niethammer D, Dannecker GE. Krull F, et al. Among authors: dohlsten m. Melanoma Res. 1997 Jun;7(3):214-22. doi: 10.1097/00008390-199706000-00005. Melanoma Res. 1997. PMID: 9195560

6

Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells.

Gidlöf C, Dohlsten M, Kalland T, Tötterman TH. Gidlöf C, et al. Among authors: dohlsten m. Leukemia. 1995 Sep;9(9):1534-42. Leukemia. 1995. PMID: 7544852

7

Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.

Dohlsten M, Hansson J, Ohlsson L, Litton M, Kalland T. Dohlsten M, et al. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9791-5. doi: 10.1073/pnas.92.21.9791. Proc Natl Acad Sci U S A. 1995. PMID: 7568219 Free PMC article.

8

Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.

Hedlund G, Dohlsten M, Petersson C, Kalland T. Hedlund G, et al. Among authors: dohlsten m. Cancer Immunol Immunother. 1993;36(2):89-93. doi: 10.1007/BF01754407. Cancer Immunol Immunother. 1993. PMID: 8425213 Free PMC article.

9

Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.

Lando PA, Dohlsten M, Hedlund G, Brodin T, Sansom D, Kalland T. Lando PA, et al. Among authors: dohlsten m. Immunology. 1993 Oct;80(2):236-41. Immunology. 1993. PMID: 7505257 Free PMC article.

10

Superantigen-induced anergy in cytotoxic CD8+ T cells.

Sundstedt A, Höidén I, Hansson J, Hedlund G, Kalland T, Dohlsten M. Sundstedt A, et al. Among authors: dohlsten m. J Immunol. 1995 Jun 15;154(12):6306-13. J Immunol. 1995. PMID: 7759869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page